Drug resistance among Mycobacterium tuberculosis strains isolated in Taiwan during 1975. 1977

K H Hsu, and T H Ueng, and S T Hsu

455 strains of Mycobacterium tuberculosis were isolated from patients with history of treatment in Taiwan Provincial Tuberculosis Control Bureau and tested for resistance against various antituberculosis agents including streptomycin (SM), paraaminosalicylic acid (PAS), isoniazid (INH), cycloserine (CS), prothionamide (1321TH), kanamycin (KM), ethambutol (EMB), and rifampicin (RFP). In vitro resistance to SM and INH was more frequently found than others and the resistance to a single drug was more common than multiple resistance.

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013624 Taiwan Country in eastern Asia, islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China. The capital is Taipei. The alternate country name is Republic of China. Formosa,Republic of China

Related Publications

K H Hsu, and T H Ueng, and S T Hsu
November 2001, Microbes and infection,
K H Hsu, and T H Ueng, and S T Hsu
November 1997, Journal of the Formosan Medical Association = Taiwan yi zhi,
K H Hsu, and T H Ueng, and S T Hsu
October 2004, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
K H Hsu, and T H Ueng, and S T Hsu
April 2021, Enfermedades infecciosas y microbiologia clinica (English ed.),
K H Hsu, and T H Ueng, and S T Hsu
July 1997, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
K H Hsu, and T H Ueng, and S T Hsu
May 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
K H Hsu, and T H Ueng, and S T Hsu
January 2015, Polish journal of microbiology,
K H Hsu, and T H Ueng, and S T Hsu
April 2002, Enfermedades infecciosas y microbiologia clinica,
K H Hsu, and T H Ueng, and S T Hsu
January 1996, Revista cubana de medicina tropical,
Copied contents to your clipboard!